メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
リンクは新しいタブで開きます
English
日本語
Keio Universityでコンテンツを検索
ホーム
プロファイル
研究部門
研究成果
Scopus著者プロファイル
中原 仁
内科学(神経)
ウェブサイト
https://k-ris.keio.ac.jp/html/100003279_ja.html
h-index
4961
被引用数
31
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2001
2026
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(192)
類似のプロファイル
(6)
フィンガープリント
Jin Nakaharaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Japan
100%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
74%
Multiple Sclerosis
57%
Migraine
55%
Myasthenia Gravis
48%
Spreading Depolarization
38%
Satralizumab
35%
Demyelination
33%
Japanese Patients
33%
Headache
33%
Eculizumab
31%
Oligodendrocyte Precursor Cells
29%
Multiple Sclerosis Treatment
28%
Neurology
26%
Calcitonin Gene-related Peptide Monoclonal Antibody
26%
Clinical Trials
26%
Interim Analysis
25%
Amyotrophic Lateral Sclerosis
25%
Ischemic Stroke
24%
Neurological Diseases
22%
Induced Pluripotent Stem Cells (iPSCs)
21%
Long-term Efficacy
21%
Post-marketing Surveillance
20%
Parkinson's Disease
20%
Anti-CGRP Monoclonal Antibodies
19%
Capillary
19%
Aquaporin-4 (AQP4)
19%
Single Center
18%
Myelin
17%
Acetylcholine Receptor Antibody
17%
Myelin Basic Protein
17%
Clinical Characteristics
16%
Migraine Symptoms
16%
95% Confidence Interval
16%
Amyloid Precursor Protein
16%
Oligodendrocyte Precursor Cell Differentiation
15%
Japanese Society of Neurology
14%
Alzheimer's Disease
14%
Alzheime's Disease
14%
Paroxysmal Atrial Fibrillation
14%
Cell-based
14%
COVID-19
14%
Central Nervous System
14%
Favorable Outcome
13%
Multiple Sclerosis Lesions
13%
Anesthetized Mice
13%
Photophobia
13%
Fc Receptor
13%
Long-term Safety
13%
Atrial Fibrillation
13%
Neuroscience
Multiple Sclerosis
98%
Migraine
60%
Oligodendrocyte
54%
Neuromyelitis Optica
36%
Myelin
32%
Cerebrovascular Accident
30%
Parkinson's Disease
30%
Alzheimer's Disease
29%
Headache
29%
Eculizumab
28%
Remyelinization
26%
Magnetic Resonance Imaging
26%
Calcitonin Gene Related Peptide
26%
Aquaporin 4 Antibody
21%
Monoclonal Antibody
21%
Central Nervous System
20%
Fc Receptor
20%
Astrocyte
19%
Myelinogenesis
19%
In Vivo
19%
Brain Ischemia
17%
Calcitonin Gene-Related Peptide
17%
Myasthenia gravis
16%
Biological Marker
16%
Amyloid Precursor Protein
16%
Muscle Disorder
14%
Galcanezumab
14%
Cerebral Hemorrhage
14%
Microglia
14%
Cognitive Disorders
14%
Placebo
13%
Immune Checkpoint Inhibitor
12%
Trigeminal Ganglion
12%
Amyotrophic Lateral Sclerosis
12%
Atrial Fibrillation
12%
Ofatumumab
12%
Middle Cerebral Artery
12%
Amyloid Protein
11%
Myelin Basic Protein
10%
Cellular Differentiation
10%
Glial Fibrillary Acidic Protein
10%
Autoantibodies
10%
Nucleus
9%
Dysautonomia
9%
Positron Emission Tomography
9%
Cholinergic Receptor Antibody
9%
Thrombectomy
8%
Multiple System Atrophy
8%
Axon
8%
Immunoglobulin Fc Fragment
8%
Medicine and Dentistry
Multiple Sclerosis
83%
Migraine
40%
Remyelination
35%
Diseases
30%
Apoplexy
29%
Myelin
29%
Cerebral Hemorrhage
28%
Headache
27%
Neuromyelitis Optica
25%
Myasthenia gravis
25%
Observational Study
22%
Monoclonal Antibody
22%
Magnetic Resonance Imaging
21%
Neurologic Disease
21%
Parkinson's Disease
20%
Calcitonin Gene Related Peptide
19%
Alzheimer's Disease
19%
Satralizumab
19%
Capillary
19%
Interim Analysis
19%
Brain Ischemia
16%
Tau
16%
Neurology
16%
Fingolimod
14%
Demyelination
13%
Cognitive Defect
13%
Disease Modifying Therapy
13%
Oral
13%
Clinical Trial
12%
Atrial Fibrillation
12%
Ofatumumab
12%
Patient Monitoring
12%
Cross Sectional Study
12%
Myopathy
12%
Myositis
12%
Progressive Multifocal Leukoencephalopathy
12%
Anemia
12%
Imaging Technique
12%
Methylprednisolone
11%
Pathogenesis
11%
Infection
11%
Prevalence
10%
Quality of Life
10%
Central Nervous System
10%
Antithrombotic
10%
Biological Marker
10%
Warfarin
10%
Amyloid Protein
10%
Shy-Drager Syndrome
9%
Glucocorticoid
9%
